Aprutumab, {a unique antibody-drug conjugate, offers {a potential advance in combating cancers driven by FGFR2 alterations. This targeted therapy operates by directly inhibiting FGFR2, a tyrosine kinase often https://www.targetmol.com/compound/aprutumab
{Aprutumab: A Promising Hope for FGFR2-Driven Tumors
Internet - 4 hours ago fgfr2-ttc101132Web Directory Categories
Web Directory Search
New Site Listings